Veradermics, Inc. (MANE)
143.00
+4.22
(+3.04%)
USD |
NYSE |
Nov 09, 10:50
Veradermics Shareholders Equity (Quarterly) : 814.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 814.21M |
| March 31, 2026 | 391.87M |
| December 31, 2025 | 145.31M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 54.66M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 40.27B |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 826.33M |
| Total Liabilities (Quarterly) | 12.12M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 70.53 |
| Net Debt Paydown Yield | 0.00% |